Results 61 to 70 of about 166,938 (112)

Olipudase alfa for the treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30months [PDF]

open access: yesMolecular Genetics and Metabolism, 2017
Ana Cristina Puga   +7 more
openaire   +1 more source

Alfa Card

open access: yes
Card for Alfa, a hotel, restaurant, and garage.
Alfa Hotel
core  

Alfa-Cakes-Fabrik G.m.b.H, Radebeul-Dresden, Befreiungshalle.

open access: yes
ALFA-CAKES-FABRIK G.M.B.H, RADEBEUL-DRESDEN, BEFREIUNGSHALLE. Alfa-Cakes-Fabrik G.m.b.H, Radebeul-Dresden, Befreiungshalle. ( -
Alfa-Cakes-Fabrik G.m.b.H.
core   +1 more source

O33: Impact of p.Arg610del neuroprotective genotype on disease burden and treatment response in adults with acid-sphingomyelinase deficiency: ASCEND olipudase alfa trial

open access: yesGenetics in Medicine Open
Melissa Wasserstein   +6 more
doaj   +1 more source

P206: Continued clinical improvements in adults with acid sphingomyelinase deficiency after 3-5 Years of olipudase alfa treatment: Final ASCEND trial results

open access: yesGenetics in Medicine Open
Melissa Wasserstein   +19 more
doaj   +1 more source

P034: A real-world evidence study into the usage of olipudase alfa for acid sphingomyelinase deficiency in the United States

open access: yesGenetics in Medicine Open
Judy Hull   +5 more
openaire   +1 more source

Screening for acid sphingomyelinase deficiency in patients with an interstitial lung disease. [PDF]

open access: yesOrphanet J Rare Dis
Vermant M   +12 more
europepmc   +1 more source

1973. Domenico Rea a Alfa Romeo - Alfa sud

open access: yes, 1973
Rea, Domenico, Alfa Romeo - Alfasud
core   +1 more source

Home - About - Disclaimer - Privacy